The Latest Breaking News from FDA

Juul decision triggers broader tobacco fight

FDA's Juul ban could trigger grinding fight over smoking rules

Axios · Jun 24, 2022

These machines to help people breathe were recalled a year ago. Many still use them

In Rochester, New York, Diane Coleman has relied on a machine to help her stay alive, but she worries that it might be slowly undermining her health.

Los Angeles Times · Jun 24, 2022

Sarepta Therapeutics' Shares Plummet Following FDA's Clinical Hold On MOMENTUM Study

The U.S. Food and Drug Administration (FDA) has placed a clinical hold on SRP-5051 (vesleteplirsen), Sarepta Therapeutics' (NASDAQ: SRPT) lead candidate to treat patients with Duchenne muscular dystrophy.

Benzinga · Jun 23, 2022

Jif peanut butter recalls continue

A West Virginia-based candy maker joins a list of companies who have also pulled Jif products from their shelves

Salon · Jun 23, 2022

44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More

 Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.

Benzinga · Jun 23, 2022

E-cigarettes: FDA bans market-leading Juul in blow to US tobacco industry

Action is part of effort by Food and Drug Administration to bring scientific scrutiny to multibillion-dollar vaping industry

The Guardian - US · Jun 23, 2022

Bone Health Focused Radius Health Goes Private In $890M Deal

Radius Health Inc (NASDAQ:RDUS) will be acquired by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately $890 million, including the assumption of debt and assuming full payment of the CVR (Contingent Value Right).  Gurnet Point and Patient Square will pay $10.00 per share in cash plus a…

Benzinga · Jun 23, 2022

Tucker Carlson says Biden’s nicotine crackdown will make people ‘easier to control’

The CDC says smoking is the leading cause of death in the US, accounting for 480,000 deaths each year

The Independent UK · Jun 23, 2022

SIGA Technologies Announces $13M Worth Order For Its Monkeypox Treatment

SIGA Technologies Inc (NASDAQ:SIGA) has announced approximately $13 million in procurement orders for oral TPOXX (tecovirimat) The order includes $11 million for initial procaurement from two new international jurisdictions and an approximate $2 million order from a country in the Asia Pacific region with an established contract for oral TPOXX. "We expect a…

Benzinga · Jun 23, 2022

FDA bans Juul e-cigs, parents everywhere rejoice

The Food and Drug Administration is planning to make an example out of Juul, but e-cig enthusiasts don't need to panic just yet.

Input · Jun 23, 2022